Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer.

Item

http://www.wikidata.org/entity/Q38457425

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Phase II study to assess the e ...... nt advanced urothelial cancer.

@en

type

Item

label

Phase II study to assess the e ...... nt advanced urothelial cancer.

@en

prefLabel

Phase II study to assess the e ...... nt advanced urothelial cancer.

@en

P1476

Phase II study to assess the e ...... nt advanced urothelial cancer.

@en

P2093

Anna Osmukhina

http://www.w3.org/2001/XMLSchema#string

Arkadiusz Z Dudek

http://www.w3.org/2001/XMLSchema#string

Christian Wülfing

http://www.w3.org/2001/XMLSchema#string

Gary Hudes

http://www.w3.org/2001/XMLSchema#string

Graham Mead

http://www.w3.org/2001/XMLSchema#string

Jacqueline Vuky

http://www.w3.org/2001/XMLSchema#string

Jeffrey Skolnik

http://www.w3.org/2001/XMLSchema#string

Jianguo Li

http://www.w3.org/2001/XMLSchema#string

John Chester

http://www.w3.org/2001/XMLSchema#string

José Angel Arranz

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refracto

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen

The spindle: a dynamic assembly of microtubules and motors.

Antitumor activity of a kinesin inhibitor.

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia

Measuring the clinical response. What does it mean?

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors

P2888

s10637-013-9926-y

P304

1001-1007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-013-9926-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc-Oliver Grimm

P577

2013-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048652387

http://www.w3.org/2001/XMLSchema#string

P698

23329066

http://www.w3.org/2001/XMLSchema#string